cabozantinib,atezolizumab
exelixis,roche
['cosmic021', 'pdl']
cosmic021 cabo-atezo and cabo alone ph2. negligible activity with cabo alone. increased orrs with combo. pfs 4.5 combo, 3.4 mono os combo 13.8 vs 9.4. numerical benefit with increasing pdl1. 40% traes needing dr for combo #asco22 
Thoracic Oncologist @royalmarsdenNHS, Professor @ICR_London; Chair @BTOGorg; views are my own. Wear a mask, keep distant, get the vaccine & then a booster!